Intercept Pharmaceuticals, Inc.

CHARLES SCHWAB INVESTMENT MANAGEMENT INC

Report date

9/30/2023

Quarter

2023 Q3

Filed

11/8/2023

Shares

109,717

Value ($000)

2,034

Weight

0.0%

2013 Q4 - 2023 Q3 (19 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q3	11/8/2023	2,034	0.0%	109,717	9/30/2023
2023 Q2	8/10/2023	1,757	0.0%	158,878	6/30/2023
2023 Q1	5/12/2023	4,488	0.0%	334,169	3/31/2023
2022 Q4	2/13/2023	3,435	0.0%	277,708	12/31/2022
2022 Q3	11/14/2022	2,262	0.0%	162,135	9/30/2022
2022 Q2	8/15/2022	2,237	0.0%	161,920	6/30/2022
2022 Q1	5/13/2022	2,894	0.0%	177,860	3/31/2022
2021 Q4	2/11/2022	1,065	0.0%	65,319	12/31/2021
2021 Q3	11/16/2021	1,043	0.0%	70,211	9/30/2021
2021 Q2	8/16/2021	3,727	0.0%	186,593	6/30/2021
2021 Q1	5/17/2021	4,087	0.0%	177,040	3/31/2021
2020 Q4	2/16/2021	5,007	0.0%	202,701	12/31/2020
2020 Q3	11/13/2020	8,337	0.0%	201,070	9/30/2020
2020 Q2	8/20/2020	9,769	0.0%	203,903	6/30/2020
2020 Q1	5/15/2020	10,566	0.0%	167,817	3/31/2020
2019 Q4	2/7/2020	20,300	0.0%	163,811	12/31/2019
2014 Q2	7/30/2014	3,995	0.0%	16,879	6/30/2014
2014 Q1	4/29/2014	8,740	0.0%	26,499	3/31/2014
2013 Q4	2/14/2014	1,490	0.0%	21,810	12/31/2013